We’re now accepting proposals for our newest women’s health program – The Missed Vital Sign. Submit your application before 30 June 2025, 11:59pm ET. Learn more:

Meet the global team selected for Wellcome Leap’s $50M CARE (Cutting Alzheimer’s Risk through Endocrinology) program!. Focused on reducing Alzheimer’s risk in women, CARE aims to cut the lifetime risk in half, potentially preventing over 50 million cases by 2050.

We’re now accepting abstract submissions for our new $50M program, which aims to show the advances in women’s health that become possible when menstruation is treated as a vital sign. Submit by 16 May 2025, 11:59pm ET. Learn more here:

We are now accepting proposal submissions for our CARE program. Submit your application before 28 April 2025, 11:59pm ET. Learn more:

Every minute, somewhere in the US, a woman requires a blood transfusion because of her menstruation. Today, we are announcing a new $50M program to reduce the time it takes a woman to get effective treatment from 5 years to 5 months.

🚀 Get ready! This week, we’ll be unveiling the details of our new $50M program. #Staytuned.

Announcing Phase 3 awards in our Quantum for Bio Supported Challenge Program aimed at accelerating the applications of quantum computing in human health. Congratulations!.

Our new $50M program, which aims to cut the lifetime risk of Alzheimer's disease among women by half, is open for abstract submissions. Upload your abstract and submit by 11:59pm ET on 14 March, 2025.

Worldwide, someone develops Alzheimer’s disease every 3.2 seconds. Nearly two-thirds of all patients are women. Today, we are announcing a new $50M program to cut the risk for women by half. Learn More:

Tomorrow, we are announcing our new $50M program in Women's Health. Learn More:

Announcing Phase 2 awards in our Quantum for Bio supported challenge program. Congratulations! .

Worldwide, someone dies from drug or alcohol addiction every 4 minutes. Wellcome Leap's $50M Untangling Addiction program seeks breakthroughs that will quantify addiction susceptibility and reduce the risk of relapse. Learn more:

Tomorrow, we are revealing the details of our new $50M program.

Congratulations to physician, scientist, and Wellcome Leap R3 Performer, Drew Weissman, and his research collaborator, Katalin Karikó, for winning the 2023 Nobel Prize in Physiology / Medicine — what a difference a breakthrough can make! @WeissmanLab.

Announcing the global team of performers selected for Wellcome Leap's Dynamic Resilience program. The $60M program, jointly funded with Temasek Trust, seeks breakthroughs that will enable more resilience as we age. Learn more:

Announcing the international team selected to take on Wellcome Leap's Quantum for Bio Challenge! . The Quantum for Bio (Q4Bio) program supports the development of new quantum computing algorithms for health applications. Learn more: #quantumcomputing

RT @JeremyFarrar: Always inspiring to work with Regina Dugan, a refreshingly different way of thinking & acting, a constructive disrupter,….

The @FinancialTimes today featured Wellcome Leap's CEO Regina E. Dugan. “That’s the way we think about these programmes and problems, we look for the intersection between that which we think could be possible and that which will make a difference in the world.”.

For people living with depression, getting better answers, sooner, is the hope. What if a global team of scientists and doctors, working together, could make that hope a reality? . For more information, visit #mentalhealthawareness.#mentalhealth

Treatment for depression can feel too random— try something, see if it works, try again. At Wellcome Leap, we’re building a future where treatments work the first time, so you or someone you love can stop rolling the dice. #mentalhealthawareness